Skip to content
MDT·NYSE·US

Medtronic

Medtronic, headquartered in Galway, Ireland, is a global healthcare technology company founded in 1949 that serves healthcare systems, physicians, clinicians, and patients in more than 150 countries. It operates through three reportable segments—the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio—that develop, manufacture, distribute, and sell device-based medical therapies and services.

Source: SEC 10-K Jun 18, 2026

Recent Activity

Updated Sep 24, 2026
–Medtronic raised the lower end of its fiscal 2027 profit forecast and its revenue growth outlook on September 1, citing rising demand for heart devices.
–Medtronic began the final steps to separate its MiniMed diabetes business.
–CEO Geoff Martha said the separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios.
–Medtronic CFO Thierry Piéton said the company's growth will be driven by its focus on acute procedures, an expanding innovation pipeline, and increased targeted M&A.
–Piéton pointed to GI Genius, Medtronic's AI-enabled endoscopy platform, which he said detects 50% more polyps during a typical endoscopy procedure than a trained physician using standard methods.

Past updates are part of the Pro plan.

Thematic Position

MDT

Relationship Groups

Suppliers1
Partners3
Competitors5

Relationship details are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade policy
US and China tariffs on imported goods create cost and trade uncertainty
SEC 10-QSep 3, 2026

The full regulatory passage is part of the Pro plan.

11 more · Regulatory and geopolitical insights are part of the Pro plan.